Search

Your search keyword '"Balsam, P"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Balsam, P" Remove constraint Author: "Balsam, P" Topic atrial fibrillation Remove constraint Topic: atrial fibrillation
45 results on '"Balsam, P"'

Search Results

1. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study.

2. Practical use case of natural language processing for observational clinical research data retrieval from electronic health records: AssistMED project.

3. Greater distance between ablation lines reduces the arrhythmia recurrence rate after pulmonary vein isolation.

4. Safety and effectiveness of very-high-power, short-duration ablation in patients with atrial fibrillation: Preliminary results.

5. Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP-AF general long-term registry.

6. Autoantibodies in Atrial Fibrillation-State of the Art.

7. Antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation and sex differences: Insights from the CANT II Study.

8. Flecainide in clinical practice.

9. Administrative Data in Cardiovascular Research-A Comparison of Polish National Health Fund and CRAFT Registry Data.

10. Extracellular Vesicles in Atrial Fibrillation-State of the Art.

11. Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of a multicenter registry (CANT II Study).

12. Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study.

13. District versus academic hospitals: clinical outcomes of patients with atrial fibrillation.

14. Vascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP-AF General Long-Term Registry.

15. Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center.

16. Trends in antithrombotic management of patients with atrial fibrillation. A report from the Polish part of the EURObservational Research Programme - Atrial Fibrillation General Long-Term Registry.

17. Randomized controlled clinical trials versus real-life atrial fibrillation patients treated with oral anticoagulants. Do we treat the same patients?

18. Effectiveness comparison of various atrial fibrillation ablation methods in patients with common venous trunk.

19. OCULUS study: Virtual reality-based education in daily clinical practice.

20. Effect of β-blockers on 1-year survival and hospitalizations in patients with heart failure and atrial fibrillation: results from ESC-HF Pilot and ESC-HF Long-Term Registry.

21. Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study.

22. District versus academic hospitals: differences in the clinical characteristics of patients with atrial fibrillation without valvular heart disease treated with oral anticoagulants

24. Use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation - Messages from the 2018 EHRA.

25. Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study.

26. NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study.

27. The influence of the atrial fibrillation episode duration on the endothelial function in patients treated with pulmonary veins isolation.

28. Clinical characteristics and predictors of one-year outcome of heart failure patients with atrial fibrillation compared to heart failure patients in sinus rhythm.

29. Antazoline for termination of atrial fibrillation during the procedure of pulmonary veins isolation.

30. Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up.

31. Authors' response.

32. Influence of left atrial size on the outcome of pulmonary vein isolation in patients with atrial fibrillation.

33. Efficacy of multi-electrode duty-cycled radiofrequency ablation in patients with paroxysmal and persistent atrial fibrillation.

34. Clinical outcomes and predictors of long-term mortality, hemorrhagic and thromboembolic events in atrial fibrillation patients at different stages of chronic kidney disease: The CRAFT trial

35. Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP‐AF general long‐term registry

36. Reduction of myocardial necrosis using 'CLOSE' protocol during pulmonary vein isolation—Preliminary results from ACTIVE‐AF trial

37. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

38. Impact of renal impairment on atrial fibrillation

39. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

40. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation:a report from ESC-EHRA EORP-AF Long-Term General Registry

41. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

42. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

43. Atrial fibrillation history impact on catheter ablation outcome. Findings from the ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry

44. Reduction of myocardial necrosis using "CLOSE" protocol during pulmonary vein isolation—Preliminary results from ACTIVE‐AF trial.

45. The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation:a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists

Catalog

Books, media, physical & digital resources